[Therapeutic study of glutamic acid combined with a new organic phosphorus compound, ditetraethylammonium phosphate].
D004038:Diet, Reducing; D005971:Glutamates / Q000627:therapeutic use*; D018698:Glutamic Acid; D008607:Intellectual Disability / Q000628:therapy*; D009497:Neurotic Disorders; D009943:Organophosphorus Compounds; D010710:Phosphates; D019789:Tetraethylammonium / Q000627:therapeutic use*; D013831:Thiamine / Q000627:therapeutic use*
D005971:Glutamates; D009943:Organophosphorus Compounds; D010710:Phosphates; D018698:Glutamic Acid; D019789:Tetraethylammonium; D013831:Thiamine
GLUTAMATES/therapeutic use; MENTAL DEFICIENCY/therapy; NEUROSES; TETRAETHYLAMMONIUM/therapeutic use; VITAMIN B1/therapeutic use
Considerazioni terapeutiche sull'associazione dell'acido glutammico ad un nuovo composto di fosforo organico: fosfato di ditetraetilammonio.